These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28366727)

  • 21. Elexacaftor/VX-445-mediated CFTR interactome remodeling reveals differential correction driven by mutation-specific translational dynamics.
    Kim M; McDonald EF; Sabusap CMP; Timalsina B; Joshi D; Hong JS; Rab A; Sorscher EJ; Plate L
    J Biol Chem; 2023 Oct; 299(10):105242. PubMed ID: 37690692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive mapping of cystic fibrosis mutations to CFTR protein identifies mutation clusters and molecular docking predicts corrector binding site.
    Molinski SV; Shahani VM; Subramanian AS; MacKinnon SS; Woollard G; Laforet M; Laselva O; Morayniss LD; Bear CE; Windemuth A
    Proteins; 2018 Aug; 86(8):833-843. PubMed ID: 29569753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correctors of the Major Cystic Fibrosis Mutant Interact through Membrane-Spanning Domains.
    Laselva O; Molinski S; Casavola V; Bear CE
    Mol Pharmacol; 2018 Jun; 93(6):612-618. PubMed ID: 29618585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of novel VX-809 hybrid derivatives as F508del-CFTR correctors by molecular modeling, chemical synthesis and biological assays.
    Parodi A; Righetti G; Pesce E; Salis A; Tasso B; Urbinati C; Tomati V; Damonte G; Rusnati M; Pedemonte N; Cichero E; Millo E
    Eur J Med Chem; 2020 Dec; 208():112833. PubMed ID: 32971410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rescue of CFTR NBD2 mutants N1303K and S1235R is influenced by the functioning of the autophagosome.
    Liu Q; Sabirzhanova I; Yanda MK; Bergbower EAS; Boinot C; Guggino WB; Cebotaru L
    J Cyst Fibros; 2018 Sep; 17(5):582-594. PubMed ID: 29936070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correctors promote maturation of cystic fibrosis transmembrane conductance regulator (CFTR)-processing mutants by binding to the protein.
    Wang Y; Loo TW; Bartlett MC; Clarke DM
    J Biol Chem; 2007 Nov; 282(46):33247-33251. PubMed ID: 17911111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanistic Approaches to Improve Correction of the Most Common Disease-Causing Mutation in Cystic Fibrosis.
    Bali V; Lazrak A; Guroji P; Matalon S; Bebok Z
    PLoS One; 2016; 11(5):e0155882. PubMed ID: 27214033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Folding correctors can restore CFTR posttranslational folding landscape by allosteric domain-domain coupling.
    Soya N; Xu H; Roldan A; Yang Z; Ye H; Jiang F; Premchandar A; Veit G; Cole SPC; Kappes J; Hegedüs T; Lukacs GL
    Nat Commun; 2023 Oct; 14(1):6868. PubMed ID: 37891162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the mechanism of action of RDR01752, a novel corrector of F508del-CFTR.
    Lopes-Pacheco M; Silva IAL; Turner MJ; Carlile GW; Sondo E; Thomas DY; Pedemonte N; Hanrahan JW; Amaral MD
    Biochem Pharmacol; 2020 Oct; 180():114133. PubMed ID: 32628927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The CFTR Corrector, VX-809 (Lumacaftor), Rescues ABCA4 Trafficking Mutants: a Potential Treatment for Stargardt Disease.
    Liu Q; Sabirzhanova I; Bergbower EAS; Yanda M; Guggino WG; Cebotaru L
    Cell Physiol Biochem; 2019; 53(2):400-412. PubMed ID: 31403270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measurements of Functional Responses in Human Primary Lung Cells as a Basis for Personalized Therapy for Cystic Fibrosis.
    Awatade NT; Uliyakina I; Farinha CM; Clarke LA; Mendes K; Solé A; Pastor J; Ramos MM; Amaral MD
    EBioMedicine; 2015; 2(2):147-53. PubMed ID: 26137539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correctors promote folding of the CFTR in the endoplasmic reticulum.
    Loo TW; Bartlett MC; Clarke DM
    Biochem J; 2008 Jul; 413(1):29-36. PubMed ID: 18361776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PTI-801 (posenacaftor) shares a common mechanism with VX-445 (elexacaftor) to rescue p.Phe508del-CFTR.
    Ferreira FC; Amaral MD; Bacalhau M; Lopes-Pacheco M
    Eur J Pharmacol; 2024 Mar; 967():176390. PubMed ID: 38336013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rescue of Rare CFTR Trafficking Mutants Highlights a Structural Location-Dependent Pattern for Correction.
    Zacarias S; Batista MSP; Ramalho SS; Victor BL; Farinha CM
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correctors of ΔF508 CFTR restore global conformational maturation without thermally stabilizing the mutant protein.
    He L; Kota P; Aleksandrov AA; Cui L; Jensen T; Dokholyan NV; Riordan JR
    FASEB J; 2013 Feb; 27(2):536-45. PubMed ID: 23104983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Searching for combinations of small-molecule correctors to restore f508del-cystic fibrosis transmembrane conductance regulator function and processing.
    Boinot C; Jollivet Souchet M; Ferru-Clément R; Becq F
    J Pharmacol Exp Ther; 2014 Sep; 350(3):624-34. PubMed ID: 24970923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Processing mutations disrupt interactions between the nucleotide binding and transmembrane domains of P-glycoprotein and the cystic fibrosis transmembrane conductance regulator (CFTR).
    Loo TW; Bartlett MC; Clarke DM
    J Biol Chem; 2008 Oct; 283(42):28190-7. PubMed ID: 18708637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct interaction of a CFTR potentiator and a CFTR corrector with phospholipid bilayers.
    Baroni D; Zegarra-Moran O; Svensson A; Moran O
    Eur Biophys J; 2014 Jul; 43(6-7):341-6. PubMed ID: 24771136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physiological and pharmacological characterization of the N1303K mutant CFTR.
    DeStefano S; Gees M; Hwang TC
    J Cyst Fibros; 2018 Sep; 17(5):573-581. PubMed ID: 29887518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Revertants, low temperature, and correctors reveal the mechanism of F508del-CFTR rescue by VX-809 and suggest multiple agents for full correction.
    Farinha CM; King-Underwood J; Sousa M; Correia AR; Henriques BJ; Roxo-Rosa M; Da Paula AC; Williams J; Hirst S; Gomes CM; Amaral MD
    Chem Biol; 2013 Jul; 20(7):943-55. PubMed ID: 23890012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.